Remember that these estimates are speculative
A more evidence-based way to evaluate whether something is helping is to track measurable outcomes with your clinician (for example, symptoms tied to confirmed deficiency, or objective metrics like body weight, waist measurements, and lab work when appropriate)
Key findings of the study are as follows: 76 of 145 410 patients (incidence rate 1.33 events per 10 000 person years) treated with GLP1 receptor agonists and 184 of 291 667 patients (incidence rate 1.46 events per 10 000 person years) treated with DPP4 inhibitors developed thyroid cancer
Use the PepPal calculator for exact unit conversions at any concentration
ND refers to assays that exhibited no detectable activity
Our team in Sandy, UT, combines medical expertise with personalized care to help you optimize tissue repair and recovery using the latest regenerative medicine advances